Healthcare -
Biotechnology - NASDAQ - US
$ 18.33
-3.53 %
$ 32.7 M
Market Cap
-2.72
P/E
Price Target
Average
74.58%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
39.71%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cadrenal Therapeutics, Inc. Common Stock
Wall Street analysts predict an average 1-year price target for CVKD of $32 , with forecasts ranging from
a
low of
$32 to a high of $32 .
CVKD Lowest Price Target
Wall Street Target
32 USD
74.58%
CVKD Average Price Target
Wall Street Target
32 USD
74.58%
CVKD Highest Price Target
Wall Street Target
32 USD
74.58%
REVENUE FORECAST
Revenue Forecast Chart CVKD
EBIT FORECAST
EBIT Forecast Chart CVKD
NET INCOME FORECAST
Net Income Chart CVKD